Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 115

    1.

    Encapsidation of APOBEC3G into HIV-1 virions involves lipid raft association and does not correlate with APOBEC3G oligomerization.

    Khan MA, Goila-Gaur R, Kao S, Miyagi E, Walker RC Jr, Strebel K.

    Retrovirology. 2009 Nov 3;6:99.

    PMID:
    19886996
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.

    Huthoff H, Autore F, Gallois-Montbrun S, Fraternali F, Malim MH.

    PLoS Pathog. 2009 Mar;5(3):e1000330. Epub 2009 Mar 6.

    PMID:
    19266078
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    3.

    7SL RNA mediates virion packaging of the antiviral cytidine deaminase APOBEC3G.

    Wang T, Tian C, Zhang W, Luo K, Sarkis PT, Yu L, Liu B, Yu Y, Yu XF.

    J Virol. 2007 Dec;81(23):13112-24. Epub 2007 Sep 19.

    PMID:
    17881443
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Analysis of the contribution of cellular and viral RNA to the packaging of APOBEC3G into HIV-1 virions.

    Khan MA, Goila-Gaur R, Opi S, Miyagi E, Takeuchi H, Kao S, Strebel K.

    Retrovirology. 2007 Jul 16;4:48.

    PMID:
    17631688
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    5.

    Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.

    Wang T, Zhang W, Tian C, Liu B, Yu Y, Ding L, Spearman P, Yu XF.

    Virology. 2008 Jul 20;377(1):71-9. Epub 2008 May 21.

    PMID:
    18495196
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    6.

    Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.

    Friew YN, Boyko V, Hu WS, Pathak VK.

    Retrovirology. 2009 Jun 4;6:56.

    PMID:
    19497112
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    7.

    Identification of amino acid residues in APOBEC3G required for regulation by human immunodeficiency virus type 1 Vif and Virion encapsidation.

    Huthoff H, Malim MH.

    J Virol. 2007 Apr;81(8):3807-15. Epub 2007 Jan 31.

    PMID:
    17267497
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    Amino-terminal region of the human immunodeficiency virus type 1 nucleocapsid is required for human APOBEC3G packaging.

    Luo K, Liu B, Xiao Z, Yu Y, Yu X, Gorelick R, Yu XF.

    J Virol. 2004 Nov;78(21):11841-52.

    PMID:
    15479826
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    9.

    Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.

    Walker RC Jr, Khan MA, Kao S, Goila-Gaur R, Miyagi E, Strebel K.

    J Virol. 2010 May;84(10):5201-11. Epub 2010 Mar 10.

    PMID:
    20219919
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Identification of amino acid residues in HIV-1 Vif critical for binding and exclusion of APOBEC3G/F.

    Yamashita T, Kamada K, Hatcho K, Adachi A, Nomaguchi M.

    Microbes Infect. 2008 Aug-Sep;10(10-11):1142-9. Epub 2008 Jun 18.

    PMID:
    18603011
    [PubMed - indexed for MEDLINE]
    11.

    Targeting APOBEC3A to the viral nucleoprotein complex confers antiviral activity.

    Goila-Gaur R, Khan MA, Miyagi E, Kao S, Strebel K.

    Retrovirology. 2007 Aug 29;4:61.

    PMID:
    17727729
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    12.

    APOBEC3G complexes decrease human immunodeficiency virus type 1 production.

    Martin KL, Johnson M, D'Aquila RT.

    J Virol. 2011 Sep;85(18):9314-26. Epub 2011 Jul 13.

    PMID:
    21752914
    [PubMed - indexed for MEDLINE]
    13.

    The cellular source for APOBEC3G's incorporation into HIV-1.

    Ma J, Li X, Xu J, Zhang Q, Liu Z, Jia P, Zhou J, Guo F, You X, Yu L, Zhao L, Jiang J, Cen S.

    Retrovirology. 2011 Jan 6;8:2. Retraction in: Retrovirology. 2011;8:88.

    PMID:
    21211018
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.

    Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A.

    J Exp Med. 2010 Jan 18;207(1):39-49. Epub 2009 Dec 28.

    PMID:
    20038599
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    15.

    Functional analysis and structural modeling of human APOBEC3G reveal the role of evolutionarily conserved elements in the inhibition of human immunodeficiency virus type 1 infection and Alu transposition.

    Bulliard Y, Turelli P, Röhrig UF, Zoete V, Mangeat B, Michielin O, Trono D.

    J Virol. 2009 Dec;83(23):12611-21. Epub 2009 Sep 23.

    PMID:
    19776130
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    16.

    Newly synthesized APOBEC3G is incorporated into HIV virions, inhibited by HIV RNA, and subsequently activated by RNase H.

    Soros VB, Yonemoto W, Greene WC.

    PLoS Pathog. 2007 Feb;3(2):e15.

    PMID:
    17291161
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    17.

    Reverse transcriptase- and RNA packaging signal-dependent incorporation of APOBEC3G into hepatitis B virus nucleocapsids.

    Nguyen DH, Hu J.

    J Virol. 2008 Jul;82(14):6852-61. Epub 2008 May 14.

    PMID:
    18480459
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Functional domain organization of human APOBEC3G.

    Gooch BD, Cullen BR.

    Virology. 2008 Sep 15;379(1):118-24. Epub 2008 Jul 18.

    PMID:
    18639915
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.
    20.

    Distinct domains within APOBEC3G and APOBEC3F interact with separate regions of human immunodeficiency virus type 1 Vif.

    Russell RA, Smith J, Barr R, Bhattacharyya D, Pathak VK.

    J Virol. 2009 Feb;83(4):1992-2003. Epub 2008 Nov 26.

    PMID:
    19036809
    [PubMed - indexed for MEDLINE]
    Free PMC Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk